Skip to main content
. 2017 Jul 11;8(51):89315–89325. doi: 10.18632/oncotarget.19167

Figure 1. Schematic illustration of the anti-cancer potential of HDACIs to eliminate CSCs.

Figure 1

CSCs are resistant to conventional therapies such as chemotherapy and radiation which makes the cancer incurable. Therapeutic strategy using HDACIs induces differentiation of CSCs towards cancer cells by activation of gene transcription, and thus renders the tumors sensitive to therapies.